Litcius/Paper detail

Pore forming–mediated intracellular protein delivery for enhanced cancer immunotherapy

Zhanwei Zhou, Ruoxi Yang, Jingwen Dong, Yongxiang Di, Ying Yang, Ying Huang, Xue Yang, Wei Liu, Jinqiang Wang, Peifeng Liu, Zhen Gu, Minjie Sun

2022Science Advances30 citationsDOIOpen Access PDF

Abstract

Directly delivering therapeutic proteins to their intracellular targets remains a great challenge. Here, we apply CD8 + T cells to form pores on the tumor cells’ plasma membranes, enabling perfusion of ribonuclease A (RNase A) and granzyme B into cells, therefore effectively inducing tumor apoptosis and pyroptosis by activating caspase 3 and gasdermin E pathways to potentiate the CD8 + T cell–mediated immunotherapy. Then, RNase A, programmed cell death ligand 1 antibody, and a photothermal agent were further loaded into an injectable hydrogel to treat the low immunogenic murine breast cancer. Notably, three courses of laser irradiation induced efficient cell apoptosis and immune activation, resulting in a notable therapeutic efficacy that 75% of the tumors were ablated without relapse.

Topics & Concepts

PyroptosisImmunotherapyIntracellularCancer researchApoptosisCD8Cancer cellGranzymeGranzyme BProgrammed cell deathRNase PPhotothermal therapyImmunogenic cell deathCytotoxic T cellCellImmune systemChemistryCell biologyCancerMedicineBiologyMaterials scienceImmunologyNanotechnologyBiochemistryPerforinIn vitroInternal medicineRNAGeneImmunotherapy and Immune ResponsesImmune Cell Function and InteractionInflammasome and immune disorders